A U. S. Senate Committee has alleged in a report that Medtronic Inc, a medical device maker, has used wrong ways to promote its Infuse bone graft product, which is being used in spinal surgery.

Medtronic Inc has accepted that the defects in its security insulin pumps could help hackers control the device with a remote.

However, company officials have notified that the 200,000 diabetes patients who have been using the device should not worry as the risk of the cyber attack was near to the ground.

The researchers at the Medtronic Inc. (MDT) and Eli Lilly & Co. (LLY) said that a new treatment for the Parkinson’s disease will be developed for direct delivery of the medicine in to the brain. The companies announced on Tuesday that they will work on the treatment in collaboration, which may take decades.

On Wednesday Medtronic Inc. announced that the issues highlighted in the two warning letters from the Food and Drug Administration regarding their facilities in Mounds View and Juncos, Puerto Rico have been resolved. The resolution of these issues means that critical medical devices produced in these plants can now be made ready for introduction into the United States market.

On Monday, Medtronic Inc. declared that it has resolved the patent-violation lawsuit it filed against AGA Medical Corp. in 2007.

Reuters shared that a new study has revealed that making use of a catherer to freeze heart tissue is more useful than other medications available for treatment of atrial fibrillation.

In a letter to physicians, Medtronic Inc. has warned that nearly 37,000 of its pacemakers, produced late 1990s onwards, could possibly have wiring defects due to which a malfunctioning of the medical equipment is quite possible.

In its endeavor to expand its growing diabetes business, the Minneapolis-based medical device maker Medtronic Inc. intends making 1,400 job-additions in the coming five-year period, at its new San Antonio, Texas-based customer support facility, scheduled to open late this summer.

Minneapolis-headquartered Medtronic, Inc. has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product.

Medtronic Inc’s implantable deep brain stimulator, Reclaim DBS Therapy, has received the FDA approval for facilitating the treatment process in severe cases of obsessive-compulsive disorder (OCD), in which drug and psychotherapy have been futile.